SAN DIEGO, CA – January 20, 2025 – Tanvex BioPharma, Inc. (“Tanvex”), a contract development and manufacturing organization (CDMO) for
43rd Annual J.P. Morgan Healthcare Conference Bora Pharmaceuticals has been invited to participate in the prestigious J.P. Morgan Healthcare Conference
Bora Biologics Announces Strategic Collaboration to Accelerate Key CMC Development of DotBio’s Tri-Specific Antibody to Treat Cancer TAIPEI, TAIWAN –
Bora Pharmaceuticals Announces Unveiling of New Multi-Purpose Small Molecule Site in Zhongli, Taiwan Taipei, Taiwan (January 6, 2025) – Bora
